glp-1 agonist therapy information platforms Understanding receptor agonists and their impact on drug discovery A Comprehensive Review of the
Description
Currently, in type 2 diabetes, only one ongoing study is testing combination with an SGLT2i and a nsMRA

"The key point is not just how much muscle, but how healthy and functional the muscle is," Neeland says, because the goal is always to gain strength, even while losing weight

Unlike conventional approaches that target isolated symptoms or pathways, GLP-1RAs simultaneously tackle the multifactorial etiology of ocular diseases through their pleiotropic mechanisms

& Zhang, Y

JCI Insight 2020

Diabetes Research And Clinical Practice, 172 ,